$PPCB
Propanc Biopharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Camberwell, Victoria, Australia
PPCB chart
What traders are saying about $PPCB
Latest postsPropanc Biopharma, Inc. news
- Propanc Biopharma Stock Price Forecast. Should You Buy PPCB?
StockInvest.us ·
- Propanc Biopharma, Inc. (PPCB) Seasonal returns chart
Yahoo Finance UK ·
- Propanc Biopharma (PPCB) Stock Forecast & Analyst Ratings
Moomoo ·
- Propanc Biopharma, Inc. (PPCB) stock price, news, quote and history
Yahoo Finance UK ·
- Propanc Biopharma Reports Preclinical Data with PRP & PRP plus TGF-β Inhibitor on TGF-β Pathway in Pancreatic Cancer
Yahoo Finance ·
- Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients
Yahoo Finance ·
- Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients
Yahoo Finance ·
- Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability
Yahoo Finance ·
- CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
Yahoo Finance ·
- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
Yahoo Finance ·
- Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells
Yahoo Finance ·
- Propanc Biopharma Announces Publication of Pilot Study Demonstrating Potent Anti-Tumor Efficacy of PRP Pancreatic Proenzyme Formulation in Pancreatic & Ovarian Cancer
Yahoo Finance ·
Propanc Biopharma, Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | -$18.9M | -$58.9M | -$1.8M | -$2.7M |
| Diluted EPS | $-17.62 | $-371.22 | $-35324.35 | $-1.80 |
| Total assets (year end) | – | $15.1M | $78,533 | $241,907 |
| Cash and equivalents (year end) | – | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Propanc Biopharma, Inc.
- Ticker
- PPCB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Camberwell, Victoria, Australia
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1517681
- Former names
- Propanc Health Group Corp
Frequently asked questions
What exchange is Propanc Biopharma, Inc. listed on?
Propanc Biopharma, Inc. trades on the Nasdaq under the ticker symbol PPCB.
What industry is Propanc Biopharma, Inc. in?
Propanc Biopharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Propanc Biopharma, Inc. headquartered?
Propanc Biopharma, Inc.'s business address on file with the SEC is in Camberwell, Victoria, Australia.
When does Propanc Biopharma, Inc.'s fiscal year end?
Propanc Biopharma, Inc.'s fiscal year ends on June 30.